抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Benufutamab
All
TD-HT348016_1.jpg
TD-HT348016_2.jpg
- Catalog： TD-HT348016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： GEN1029,CAS:2109730-69-8
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Benufutamab
| Catalog No. | TD-HT348016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | TRAILR2, TRAIL-R2, Death receptor 5, CD262, DR5, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9, TRAIL receptor 2, TRICK2, TNFRSF10B, KILLER, TNF-related apoptosis-inducing ligand receptor 2 |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | O14763 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | GEN1029,CAS:2109730-69-8 |
| Background | Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
Detects Recombinant Human CD262/TNFRSF10B/DR5 Protein, C-His (Cat No.: TD-HT348021) in indirect ELISA. |
|
|
SDS-PAGE for Research Grade Benufutamab. |